• OPEN AN ACCOUNT
Indian Indices
Nifty
25,405.30 -48.10
(-0.19%)
Sensex
83,146.16 -93.31
( -0.11%)
Bank Nifty
56,791.95 -207.25
( -0.36%)
Nifty IT
38,854.30 -24.80
( -0.06%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,298.76 50.34
(0.81%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.63 0.05
(0.05%)
EUR-INR
100.93 0.01
(0.01%)
GBP-INR
117.11 -0.50
(-0.43%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
82.52
182282.67
EPS(TTM)
Face Value()
Div & Yield %
83.21
2
0.44
 

nmdc ltd
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
May 10,2025
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.

For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales83.8881.17 3 356.27335.07 6
OPM %28.5113.81 -25.6619.48 -
PBDT34.4221.47 60 132.61125.45 6
PBT33.8921.33 59 130.42122.84 6
NP29.3014.68 100 100.9085.19 18